Detalhe da pesquisa
1.
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
J Clin Oncol
; 37(19): 1617-1628, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30969846